Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Calliditas Therapeutics AB NASDAQ CALT NASDAQ Stockholm CALTX Calliditas today announced the presentations of new biomarker and subgroup analyses from the Phase NefIgArd study with Nefecon TARPEYO budesonide delayed release capsulesKinpeygo in adult...
BioLineRx Ltd NASDAQ BLRX TASE BLRX a commercial stage biopharmaceutical company pursuing lifechanging therapies in oncology and rare diseases today announced encouraging data from the singlearm pilot phase of the investigatorinitiated CheMoMETPANC P...
Baudax Bio Inc the Company or Baudax Bio NASDAQ BXRX a biotechnology company focused on developing T cell receptor TCR therapies utilizing human regulatory T cells Tregs
Telix Pharmaceuticals Limited ASX TLX Telix the Company has welcomed Her Royal Highness Princess Astrid Princess of Belgium to Telix Manufacturing Solutions TMS the Companys recently inaugurated production facility in Brussels South Seneffe in the Wa...
Cosmo Pharmaceuticals NV SIX COPN XETRA C Cosmo and Glenmark Specialty SA a subsidiary of Glenmark Pharmaceuticals Ltd Glenmark today announced the signing of distribution and license agreements for Winlevi clascoterone cream in Europe and South Afr...
Calliditas Therapeutics AB Nasdaq CALT Nasdaq Stockholm CALTX Calliditas today announced that the US Food and Drug Administration FDA has granted orphan drug designation ODD to the company for the treatment of Alport syndrome with setanaxib
Repligen Corporation NASDAQRGEN a life sciences company focused on bioprocessing technology leadership today announced that it has entered into a definitive agreement to acquire privatelyheld Metenova AB Metenova of Mlndal Sweden
Sandoz a global leader in generic and biosimilar medicines today announced that the European Commission EC granted marketing authorization for the first and only biosimilar Tyruko natalizumab developed by Polpharma Biologics
AbbVie NYSE ABBV today announced that the European Commission EC has granted conditional marketing authorization for TEPKINLY epcoritamab as a monotherapy for the treatment of adult patients
Biophytis and Skyepharma a French pharmaceutical company specializing in the formulation development and production of pharmaceutical products
